A child under 16 years presenting with focal (partial) seizures — seizures that originate within networks limited to one hemisphere and may involve subjective (aura), motor, autonomic, or dyscognitive features.
This protocol addresses first-line management in the paediatric age group (ages 4 to 16 years).
Current evidence supports beginning with monotherapy. One specific anticonvulsant carries a Level A evidence rating for this paediatric age group and is the recommended first-line agent. The complete regimen — including agent selection rationale, dose titration schedule, and monitoring parameters — is available in the full structured protocol.